280 related articles for article (PubMed ID: 38711394)
1. Applications of Pyrrole and Pyridine-based Heterocycles in Cancer Diagnosis and Treatment.
Tyagi R; Yadav K; Srivastava N; Sagar R
Curr Pharm Des; 2024; 30(4):255-277. PubMed ID: 38711394
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of Novel Pyridine Bearing Biologically Active Imidiazolyl, Pyrazolyl, Oxa/thiadiazolyl and Urea Derivatives as Promising Anticancer Agents.
Hafez HN; El-Gazzar ABA
Curr Org Synth; 2020; 17(1):55-64. PubMed ID: 32103718
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Anti-cancer Activity of 3-substituted Benzoyl-4-substituted Phenyl-1H-pyrrole Derivatives.
Zhan X; Qin W; Wang S; Zhao K; Xin Y; Wang Y; Qi Q; Mao Z
Anticancer Agents Med Chem; 2017; 17(6):821-831. PubMed ID: 27671311
[TBL] [Abstract][Full Text] [Related]
4. High pressure assisted synthetic approach for novel 6,7-dihydro-5H-benzo[6,7]cyclohepta[1,2-b]pyridine and 5,6-dihydrobenzo[h]quinoline derivatives and their assessment as anticancer agents.
Behbehani H; Aryan FA; Dawood KM; Ibrahim HM
Sci Rep; 2020 Dec; 10(1):21691. PubMed ID: 33303858
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, biological evaluation and molecular modeling of novel 1H-pyrrolo[2,3-b]pyridine derivatives as potential anti-tumor agents.
Wang R; Chen Y; Yang B; Yu S; Zhao X; Zhang C; Hao C; Zhao D; Cheng M
Bioorg Chem; 2020 Jan; 94():103474. PubMed ID: 31859010
[TBL] [Abstract][Full Text] [Related]
6. Discovery of New Pyrazolopyridine, Furopyridine, and Pyridine Derivatives as CDK2 Inhibitors: Design, Synthesis, Docking Studies, and Anti-Proliferative Activity.
Abdel-Rahman AA; Shaban AKF; Nassar IF; El-Kady DS; Ismail NSM; Mahmoud SF; Awad HM; El-Sayed WA
Molecules; 2021 Jun; 26(13):. PubMed ID: 34206976
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of 2-substituted Furo[3,2-b]pyridines Under Pd/C-Cu Catalysis Assisted by Ultrasound: Their Evaluation as Potential Cytotoxic Agents.
Laxmi DS; Vardhini SV; Guttikonda VR; Rao MVB; Pal M
Anticancer Agents Med Chem; 2020; 20(8):932-940. PubMed ID: 32160853
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of pyrrolo[2,3-b]pyridine analogues as antiproliferative agents and their interaction with calf thymus DNA.
Narva S; Chitti S; Bala BR; Alvala M; Jain N; Kondapalli VG
Eur J Med Chem; 2016 May; 114():220-31. PubMed ID: 26994690
[TBL] [Abstract][Full Text] [Related]
9. A Therapeutic Journey of Pyridine-based Heterocyclic Compounds as Potent Anticancer Agents: A Review (From 2017 to 2021).
Alrooqi M; Khan S; Alhumaydhi FA; Asiri SA; Alshamrani M; Mashraqi MM; Alzamami A; Alshahrani AM; Aldahish AA
Anticancer Agents Med Chem; 2022 Aug; 22(15):2775-2787. PubMed ID: 35331100
[TBL] [Abstract][Full Text] [Related]
10. Pyrrole-containing hybrids as potential anticancer agents: An insight into current developments and structure-activity relationships.
Long L; Zhang H; Zhou Z; Duan L; Fan D; Wang R; Xu S; Qiao D; Zhu W
Eur J Med Chem; 2024 Jul; 273():116470. PubMed ID: 38762915
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of novel trifluoromethyl substituted furo[2,3-b]pyridine and pyrido[3',2':4,5]furo[3,2-d]pyrimidine derivatives as potential anticancer agents.
Naresh Kumar R; Poornachandra Y; Nagender P; Mallareddy G; Ravi Kumar N; Ranjithreddy P; Ganesh Kumar C; Narsaiah B
Eur J Med Chem; 2016 Jan; 108():68-78. PubMed ID: 26629861
[TBL] [Abstract][Full Text] [Related]
12. Discovery of 7H-pyrrolo[2,3-d]pyridine derivatives as potent FAK inhibitors: Design, synthesis, biological evaluation and molecular docking study.
Wang R; Zhao X; Yu S; Chen Y; Cui H; Wu T; Hao C; Zhao D; Cheng M
Bioorg Chem; 2020 Sep; 102():104092. PubMed ID: 32707280
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and Anticancer Activity of 3-(Substituted Aroyl)-4-(3,4,5-trimethoxyphenyl)-1H-pyrrole Derivatives.
Zhan XP; Lan L; Wang S; Zhao K; Xin YX; Qi Q; Wang YL; Mao ZM
Chem Biodivers; 2017 Feb; 14(2):. PubMed ID: 27696660
[TBL] [Abstract][Full Text] [Related]
14. Roles of Pyridine and Pyrimidine Derivatives as Privileged Scaffolds in Anticancer Agents.
Prachayasittikul S; Pingaew R; Worachartcheewan A; Sinthupoom N; Prachayasittikul V; Ruchirawat S; Prachayasittikul V
Mini Rev Med Chem; 2017; 17(10):869-901. PubMed ID: 27670581
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of novel hetero ring fused pyridine derivatives; Their anticancer activity, CoMFA and CoMSIA studies.
Santhosh Kumar G; Poornachandra Y; Kumar Gunda S; Ratnakar Reddy K; Mohmed J; Shaik K; Ganesh Kumar C; Narsaiah B
Bioorg Med Chem Lett; 2018 Jul; 28(13):2328-2337. PubMed ID: 29798826
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and bioevaluation and doking study of 1H-pyrrolo[2,3-b]pyridine derivatives bearing aromatic hydrazone moiety as c-Met inhibitors.
Wang W; Xu S; Duan Y; Liu X; Li X; Wang C; Zhao B; Zheng P; Zhu W
Eur J Med Chem; 2018 Feb; 145():315-327. PubMed ID: 29331754
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of 3-substituted-4-(4-methylthio phenyl)-1H-pyrrole derivatives as potential anticancer agents.
Lan L; Qin W; Zhan X; Liu Z; Mao Z
Anticancer Agents Med Chem; 2014; 14(7):994-1002. PubMed ID: 24372525
[TBL] [Abstract][Full Text] [Related]
18. Electrochemical synthesis and characterisation of alternating tripyridyl-dipyrrole molecular strands with multiple nitrogen-based donor-acceptor binding sites.
Tabatchnik-Rebillon A; Aubé C; Bakkali H; Delaunay T; Manh GT; Blot V; Thobie-Gautier C; Renault E; Soulard M; Planchat A; Le Questel JY; Le Guével R; Guguen-Guillouzo C; Kauffmann B; Ferrand Y; Huc I; Urgin K; Condon S; Léonel E; Evain M; Lebreton J; Jacquemin D; Pipelier M; Dubreuil D
Chemistry; 2010 Oct; 16(39):11876-89. PubMed ID: 20839373
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, biological evaluation, and docking studies of novel pyrrolo[2,3-b]pyridine derivatives as both ectonucleotide pyrophosphatase/phosphodiesterase inhibitors and antiproliferative agents.
Ullah S; El-Gamal MI; El-Gamal R; Pelletier J; Sévigny J; Shehata MK; Anbar HS; Iqbal J
Eur J Med Chem; 2021 May; 217():113339. PubMed ID: 33744686
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and docking studies of phenylpicolinamide derivatives bearing 1H-pyrrolo[2,3-b]pyridine moiety as c-Met inhibitors.
Zhu W; Wang W; Xu S; Tang Q; Luo R; Wang M; Gong P; Zheng P
Bioorg Med Chem; 2016 Feb; 24(4):812-9. PubMed ID: 26810712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]